SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-062423
Filing Date
2023-11-13
Accepted
2023-11-13 07:05:08
Documents
13
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ortx-20231113.htm   iXBRL 8-K 74017
2 EX-99.1 ortx-ex99_1.htm EX-99.1 267763
  Complete submission text file 0000950170-23-062423.txt   489094

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ortx-20231113_lab.xml EX-101.LAB 14220
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ortx-20231113.xsd EX-101.SCH 2470
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ortx-20231113_pre.xml EX-101.PRE 10952
7 EXTRACTED XBRL INSTANCE DOCUMENT ortx-20231113_htm.xml XML 4727
Mailing Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD, 3RD FLOOR LONDON X0 W6 8PW 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38722 | Film No.: 231395032
SIC: 2836 Biological Products, (No Diagnostic Substances)